This search looks for keywords in all of the website’s content. Search tips
Filter by
- Agenda(1913)
- Annex to CHMP highlights(367)
- Annual Report(91)
- Application withdrawal assessment report(276)
- Committee meeting report(882)
- COVID-19 vaccine safety update(71)
- Direct healthcare professional communication(122)
- EPAR - All authorised presentations(1978)
- EPAR - Amended Product Information(1)
- EPAR - Assessment report - Variation(2706)
- EPAR - Assessment report on maintenance of orphan designation - Initial authorisation(140)
- EPAR - Assessment report on maintenance of orphan designation - Post-authorisation(42)
- EPAR - Conditions imposed on member states for safe and effective use(112)
- EPAR - Full risk management plan(0)
- EPAR - Paediatric investigation plan compliance statement(88)
- EPAR - Procedural steps taken and scientific information after authorisation(1887)
- EPAR - Procedural steps taken before authorisation(484)
- EPAR - Product Information(1974)
- EPAR - Public assessment report(1549)
- EPAR - Risk-management-plan summary(1139)
- EPAR - Scientific conclusion(1358)
- EPAR - Scientific Discussion(504)
- EPAR - Scientific Discussion - Variation(188)
- EPAR - Steps taken after authorisation when a cutoff date has been used(170)
- Herbal - Call for data(293)
- Herbal - Herbal monograph(118)
- Herbal - HMPC assessment report(476)
- Herbal - HMPC opinion on a European Union herbal monograph(247)
- Herbal - List of references supporting the assessment report(462)
- Herbal - Overview of comments received during consultation(164)
- Herbal - Summary of assessment report for the public(120)
- Herbal – European Union herbal monograph(330)
- Herbal – European Union list entry(19)
- Leaflet(71)
- Maximum Residue Limits - Divergent opinion(2)
- Maximum Residue Limits - Opinion(88)
- Maximum Residue Limits - Report(803)
- Maximum Residue Limits - Summary of opinion(14)
- Medicine QA(456)
- Medicines under additional monitoring(22)
- Minutes(1249)
- Newsletter(299)
- Opinion outside EU - All presentations(14)
- Opinion outside EU - Assessment report - Variation(9)
- Opinion outside EU - Medicine questions and answers(1)
- Opinion outside EU - Procedural steps taken and scientific information after opinion(11)
- Opinion outside EU - Procedural steps taken before opinion(3)
- Opinion outside EU - Product information(15)
- Opinion outside EU - Public assessment report(12)
- Opinion outside EU - Risk-management-plan summary(11)
- Opinion outside EU - Scientific discussion(4)
- Opinion outside EU - Summary for the public(15)
- Opinion outside EU - Summary of opinion(3)
- Opinion outside EU - Summary of opinion - Initial authorisation(9)
- Opinion outside EU - Withdrawal assessment report(1)
- Orphan designation(2420)
- Orphan review(106)
- Other(4060)
- Overview of comments(330)
- Parallel distribution(1)
- Periodic safety update single assessment(2760)
- PIP - Notification of discontinuation of a paediatric development which is covered by an agreed PIP decision(109)
- PIP - Paediatric-investigation-plan summary(93)
- PIP decision(5478)
- Position statement(29)
- PRAC recommendation on signal(164)
- Presentation(5305)
- Press Release(1708)
- Procurement(73)
- Public Statement(485)
- Recommendation on medication errors(26)
- Recruitment(38)
- Referrals document(2773)
- Regulatory and procedural guideline(723)
- Report(1619)
- Scientific guideline(2464)
- Standard Operating Procedure - SOP(129)
- Summary of opinion(1224)
- Summary of opinion - Initial authorisation(1674)
- Supply shortage(58)
- Template or form(480)
- Withdrawal letter(290)
- Work Instruction - WIN(61)
- Work programme(151)
- (-)EPAR - Overview(1974)
- Advanced therapies(4)
- Antimicrobial resistance(0)
- Biologicals(3)
- Biosimilars(20)
- Brexit(0)
- Careers(0)
- Clinical trials(0)
- Compassionate use(0)
- Compliance and inspections(0)
- Corporate(0)
- COVID-19(13)
- Data on medicines(0)
- Early access(0)
- Fees(0)
- Generic and hybrid medicines(44)
- Governance(0)
- Innovation(1)
- Maximum residue limit(0)
- Medication error(0)
- Medicines(1962)
- Medicines for use outside the EU(0)
- Medicine shortages(0)
- Mpox(2)
- Paediatrics(1)
- Parallel distribution(0)
- Pharmacovigilance(0)
- Procurement(0)
- Product information(0)
- Quality of medicines(0)
- Rare diseases(15)
- Referrals(0)
- Regulatory and procedural guidance(0)
- Research and development(0)
- Scientific advice(0)
- Scientific guidelines(0)
- SME(0)
- Vaccines(16)
- Veterinary limited markets(0)
Search results (1974)
Tizveni : EPAR - Medicine overview
English (EN) (126.49 KB - PDF)
български (BG) (174.38 KB - PDF)
español (ES) (147.8 KB - PDF)
čeština (CS) (173.03 KB - PDF)
dansk (DA) (147.66 KB - PDF)
Deutsch (DE) (151.5 KB - PDF)
eesti keel (ET) (175.31 KB - PDF)
ελληνικά (EL) (180.57 KB - PDF)
français (FR) (150.18 KB - PDF)
hrvatski (HR) (170.97 KB - PDF)
italiano (IT) (146.43 KB - PDF)
latviešu valoda (LV) (179.22 KB - PDF)
lietuvių kalba (LT) (171.51 KB - PDF)
magyar (HU) (173.39 KB - PDF)
Malti (MT) (175.1 KB - PDF)
Nederlands (NL) (147.89 KB - PDF)
polski (PL) (173.64 KB - PDF)
português (PT) (118.18 KB - PDF)
română (RO) (170.98 KB - PDF)
slovenčina (SK) (172.25 KB - PDF)
slovenščina (SL) (170.18 KB - PDF)
Suomi (FI) (146.22 KB - PDF)
svenska (SV) (147.02 KB - PDF)
Apremilast Accord : EPAR - Medicine overview
English (EN) (197.55 KB - PDF)
български (BG) (191.94 KB - PDF)
español (ES) (178.19 KB - PDF)
čeština (CS) (218.07 KB - PDF)
dansk (DA) (196.65 KB - PDF)
Deutsch (DE) (171.78 KB - PDF)
eesti keel (ET) (154.87 KB - PDF)
ελληνικά (EL) (202.81 KB - PDF)
français (FR) (169.19 KB - PDF)
hrvatski (HR) (199.19 KB - PDF)
italiano (IT) (177.01 KB - PDF)
latviešu valoda (LV) (205.21 KB - PDF)
lietuvių kalba (LT) (198.5 KB - PDF)
magyar (HU) (199.85 KB - PDF)
Malti (MT) (218.73 KB - PDF)
Nederlands (NL) (169.41 KB - PDF)
polski (PL) (201.89 KB - PDF)
português (PT) (177.93 KB - PDF)
română (RO) (195.05 KB - PDF)
slovenčina (SK) (138.03 KB - PDF)
slovenščina (SL) (215.96 KB - PDF)
Suomi (FI) (174.25 KB - PDF)
svenska (SV) (185.18 KB - PDF)
Voydeya : EPAR - Medicine overview
English (EN) (120.14 KB - PDF)
български (BG) (142.63 KB - PDF)
español (ES) (121.53 KB - PDF)
čeština (CS) (142.54 KB - PDF)
dansk (DA) (119.74 KB - PDF)
Deutsch (DE) (124.29 KB - PDF)
eesti keel (ET) (119.62 KB - PDF)
ελληνικά (EL) (151.75 KB - PDF)
français (FR) (122.35 KB - PDF)
hrvatski (HR) (141.17 KB - PDF)
italiano (IT) (119.31 KB - PDF)
latviešu valoda (LV) (157.59 KB - PDF)
lietuvių kalba (LT) (142.36 KB - PDF)
magyar (HU) (142.98 KB - PDF)
Malti (MT) (143.95 KB - PDF)
Nederlands (NL) (120.74 KB - PDF)
polski (PL) (144.64 KB - PDF)
português (PT) (122.37 KB - PDF)
română (RO) (140.28 KB - PDF)
slovenčina (SK) (141.52 KB - PDF)
slovenščina (SL) (140.28 KB - PDF)
Suomi (FI) (117.96 KB - PDF)
svenska (SV) (119.14 KB - PDF)
Onivyde : EPAR - Medicine overview
English (EN) (144.48 KB - PDF)
български (BG) (163.28 KB - PDF)
español (ES) (136.18 KB - PDF)
čeština (CS) (160.93 KB - PDF)
dansk (DA) (135.19 KB - PDF)
Deutsch (DE) (139 KB - PDF)
eesti keel (ET) (134.25 KB - PDF)
ελληνικά (EL) (162.98 KB - PDF)
français (FR) (137.4 KB - PDF)
hrvatski (HR) (159.13 KB - PDF)
italiano (IT) (135.78 KB - PDF)
latviešu valoda (LV) (179.79 KB - PDF)
lietuvių kalba (LT) (160.52 KB - PDF)
magyar (HU) (158.36 KB - PDF)
Malti (MT) (162.68 KB - PDF)
Nederlands (NL) (135.78 KB - PDF)
polski (PL) (161.38 KB - PDF)
português (PT) (137.19 KB - PDF)
română (RO) (156.8 KB - PDF)
slovenčina (SK) (160.33 KB - PDF)
slovenščina (SL) (157.79 KB - PDF)
Suomi (FI) (134.4 KB - PDF)
svenska (SV) (134.95 KB - PDF)
Kalydeco : EPAR - Medicine overview
English (EN) (167.79 KB - PDF)
български (BG) (200.75 KB - PDF)
español (ES) (165.16 KB - PDF)
čeština (CS) (193.21 KB - PDF)
dansk (DA) (163.78 KB - PDF)
Deutsch (DE) (169.86 KB - PDF)
eesti keel (ET) (160.31 KB - PDF)
ελληνικά (EL) (202.63 KB - PDF)
français (FR) (167.24 KB - PDF)
hrvatski (HR) (195.6 KB - PDF)
italiano (IT) (164.68 KB - PDF)
latviešu valoda (LV) (199.61 KB - PDF)
lietuvių kalba (LT) (192.39 KB - PDF)
magyar (HU) (194.69 KB - PDF)
Malti (MT) (204.06 KB - PDF)
Nederlands (NL) (165.62 KB - PDF)
polski (PL) (194.41 KB - PDF)
português (PT) (166.07 KB - PDF)
română (RO) (200.49 KB - PDF)
slovenčina (SK) (191.82 KB - PDF)
slovenščina (SL) (190.47 KB - PDF)
Suomi (FI) (172.44 KB - PDF)
svenska (SV) (163.14 KB - PDF)
Zoonotic Influenza Vaccine Seqirus: EPAR - Medicine overview
English (EN) (127.12 KB - PDF)
Ibuprofen Gen.Orph : EPAR - Medicine overview
English (EN) (144.81 KB - PDF)
български (BG) (180.19 KB - PDF)
español (ES) (145.03 KB - PDF)
čeština (CS) (168.61 KB - PDF)
dansk (DA) (143.81 KB - PDF)
Deutsch (DE) (146.64 KB - PDF)
eesti keel (ET) (143.08 KB - PDF)
ελληνικά (EL) (168.54 KB - PDF)
français (FR) (146.12 KB - PDF)
hrvatski (HR) (163.47 KB - PDF)
italiano (IT) (143.24 KB - PDF)
latviešu valoda (LV) (175.08 KB - PDF)
lietuvių kalba (LT) (167.04 KB - PDF)
magyar (HU) (167.12 KB - PDF)
Malti (MT) (169.06 KB - PDF)
Nederlands (NL) (143.79 KB - PDF)
polski (PL) (169.26 KB - PDF)
português (PT) (145.17 KB - PDF)
română (RO) (165.68 KB - PDF)
slovenčina (SK) (166.5 KB - PDF)
slovenščina (SL) (163.94 KB - PDF)
Suomi (FI) (142.8 KB - PDF)
svenska (SV) (143.25 KB - PDF)
Brukinsa : EPAR - Medicine overview
English (EN) (150.83 KB - PDF)
български (BG) (177.08 KB - PDF)
español (ES) (151.29 KB - PDF)
čeština (CS) (175.09 KB - PDF)
dansk (DA) (149.91 KB - PDF)
Deutsch (DE) (153.26 KB - PDF)
eesti keel (ET) (146.79 KB - PDF)
ελληνικά (EL) (177.79 KB - PDF)
français (FR) (152.61 KB - PDF)
hrvatski (HR) (174.64 KB - PDF)
italiano (IT) (149.75 KB - PDF)
latviešu valoda (LV) (182.18 KB - PDF)
lietuvių kalba (LT) (174.46 KB - PDF)
magyar (HU) (175.79 KB - PDF)
Malti (MT) (175.84 KB - PDF)
Nederlands (NL) (150.06 KB - PDF)
polski (PL) (178.44 KB - PDF)
português (PT) (151.45 KB - PDF)
română (RO) (173.39 KB - PDF)
slovenčina (SK) (174.58 KB - PDF)
slovenščina (SL) (172.87 KB - PDF)
Suomi (FI) (148.53 KB - PDF)
svenska (SV) (148.64 KB - PDF)
Aspaveli : EPAR - Medicine overview
English (EN) (129.58 KB - PDF)
български (BG) (154.63 KB - PDF)
español (ES) (130.37 KB - PDF)
čeština (CS) (153.56 KB - PDF)
dansk (DA) (127.38 KB - PDF)
Deutsch (DE) (133.69 KB - PDF)
eesti keel (ET) (127.09 KB - PDF)
ελληνικά (EL) (166.65 KB - PDF)
français (FR) (130.04 KB - PDF)
hrvatski (HR) (153.91 KB - PDF)
italiano (IT) (127.5 KB - PDF)
latviešu valoda (LV) (161.46 KB - PDF)
lietuvių kalba (LT) (152.26 KB - PDF)
magyar (HU) (153.41 KB - PDF)
Malti (MT) (156.81 KB - PDF)
Nederlands (NL) (127.95 KB - PDF)
polski (PL) (153.77 KB - PDF)
português (PT) (130.34 KB - PDF)
română (RO) (151.39 KB - PDF)
slovenčina (SK) (153.15 KB - PDF)
slovenščina (SL) (150.86 KB - PDF)
Suomi (FI) (126.49 KB - PDF)
svenska (SV) (127.81 KB - PDF)
Reblozyl : EPAR - Medicine overview
English (EN) (137.8 KB - PDF)
български (BG) (167.15 KB - PDF)
español (ES) (137.81 KB - PDF)
čeština (CS) (163.83 KB - PDF)
dansk (DA) (138.58 KB - PDF)
Deutsch (DE) (141.69 KB - PDF)
eesti keel (ET) (134.42 KB - PDF)
ελληνικά (EL) (164.86 KB - PDF)
français (FR) (140.48 KB - PDF)
hrvatski (HR) (161.61 KB - PDF)
italiano (IT) (137.16 KB - PDF)
latviešu valoda (LV) (168.9 KB - PDF)
lietuvių kalba (LT) (160.23 KB - PDF)
magyar (HU) (160.89 KB - PDF)
Malti (MT) (164.91 KB - PDF)
Nederlands (NL) (141.04 KB - PDF)
polski (PL) (163.71 KB - PDF)
português (PT) (139.88 KB - PDF)
română (RO) (159.19 KB - PDF)
slovenčina (SK) (162.09 KB - PDF)
slovenščina (SL) (160.36 KB - PDF)
Suomi (FI) (135.3 KB - PDF)
svenska (SV) (136.01 KB - PDF)